SDMHF · Sartorius Stedim Biotech S.A./ADR
Market Cap
$20.43B
Shares
97.29M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$223.75
Open$223.75
Day$223.75–223.75
52W close$178.30–259.65
Avg vol 30d998
Short int33K · 0.0% float · 59.3d
Short vol20%
DataJan 2020–Sep 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
+9.2%
Trailing year
Short interest
0.0%
Latest settlement · 59.3 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
High
Market backdrop
VIX 15.4 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+5%
above
Price vs 50-day avg
+11%
above
RSI (14)
58
neutral
MACD trend
Positive
52-week position
56%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+10%
trailing
6-month return
−8%
trailing
YTD return
−9%
this year
Relative strength
−26%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $201 › 200d $212 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.03% of float · ▲ +8.7% MoM · 59.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
44
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
75%
annualized · 1-yr
Max drawdown
−31%
past year
ATR
3.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+5%
Bullish
Price vs 50-day avg
+11%
Bullish
RSI (14)
58
Neutral
MACD trend
Positive
Bullish
52-week position
56%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $201 › 200d $212 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.03% of float · ▲ +8.7% MoM · 59.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $178
Now $224 · 56%
Range high $260
vs 200-day avg +5%
vs 50-day avg +11%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SDMHF
this stock
Sartorius Stedim Biotech S.A./ADR
|
$20.43B | -9.0% | — | — | 0.0% |
|
ISRG
Intuitive Surgical Inc
|
$137.70B | -32.3% | +20.5% | 44.8 | 2.2% |
|
BDX
Becton Dickinson & Co
|
$50.64B | — | +8.2% | — | 3.9% |
|
MDLN
Medline Inc.
|
$42.85B | -23.5% | +11.5% | — | 3.0% |
|
RMD
Resmed Inc
|
$33.14B | -5.2% | +13.4% | 22.0 | 9.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SDMHF | +3.1% | +9.7% | -7.5% | -2.3% | -9.1% |
| SPY | +0.6% | -0.8% | +18.2% | -0.6% | +11.8% |
| vs SPY | +2.4% | +10.6% | -25.8% | -1.7% | -20.9% |